Search

everythinglearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tislelizumab can cause cutaneous lupus erythematosus.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Electrochemotherapy successfully treated skin tumors in cats without recurrence.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

New treatments for lupus show promise, but more research is needed, especially for children.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.